Geode Capital Management’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,748
| Closed | -$26.8K | – | 4731 |
|
|
2023
Q4 | $26.8K | Sell |
13,748
-42
| -0.3% | -$84 | ﹤0.01% | 4467 |
|
|
2023
Q3 | $33.2K | Buy |
+13,790
| New | +$33.9K | ﹤0.01% | 4523 |
|
|
2023
Q2 | – | Sell |
-4,765
| Closed | -$53.4K | – | 4869 |
|
|
2023
Q1 | $53.4K | Sell |
4,765
-12
| -0.3% | -$154 | ﹤0.01% | 4502 |
|
|
2022
Q4 | $54K | Buy |
4,777
+444
| +10% | +$5.16K | ﹤0.01% | 4578 |
|
|
2022
Q3 | $64K | Buy |
4,333
+3,973
| +1,104% | +$97.8K | ﹤0.01% | 4711 |
|
|
2022
Q2 | $20K | Sell |
360
-19
| -5% | -$2.76K | ﹤0.01% | 4925 |
|
|
2022
Q1 | $158K | Buy |
379
+28
| +8% | +$17.9K | ﹤0.01% | 4484 |
|
|
2021
Q4 | $342K | Hold |
351
| – | – | ﹤0.01% | 4232 |
|
|
2021
Q3 | $674K | Sell |
351
-11
| -3% | -$24.9K | ﹤0.01% | 3884 |
|
|
2021
Q2 | $962K | Sell |
362
-257
| -42% | -$847K | ﹤0.01% | 3624 |
|
|
2021
Q1 | $2.57M | Buy |
619
+68
| +12% | +$368K | ﹤0.01% | 3130 |
|
|
2020
Q4 | $3.16M | Buy |
551
+33
| +6% | +$194K | ﹤0.01% | 2839 |
|
|
2020
Q3 | $3.15M | Buy |
518
+13
| +3% | +$74.5K | ﹤0.01% | 2643 |
|
|
2020
Q2 | $2.81M | Buy |
505
+210
| +71% | +$1.09M | ﹤0.01% | 2661 |
|
|
2020
Q1 | $1.09M | Buy |
295
+83
| +39% | +$476K | ﹤0.01% | 2988 |
|
|
2019
Q4 | $1.06M | Buy |
212
+71
| +50% | +$248K | ﹤0.01% | 3259 |
|
|
2019
Q3 | $333K | Hold |
141
| – | – | ﹤0.01% | 3611 |
|
|
2019
Q2 | $410K | Hold |
141
| – | – | ﹤0.01% | 3536 |
|
|
2019
Q1 | $424K | Buy |
141
+26
| +23% | +$55.1K | ﹤0.01% | 3494 |
|
|
2018
Q4 | $132K | Buy |
115
+22
| +24% | +$33.7K | ﹤0.01% | 3804 |
|
|
2018
Q3 | $68K | Hold |
93
| – | – | ﹤0.01% | 3993 |
|
|
2018
Q2 | $91K | Buy |
93
+7
| +8% | +$24.6K | ﹤0.01% | 3886 |
|
|
2018
Q1 | $440K | Hold |
86
| – | – | ﹤0.01% | 3445 |
|
|
2017
Q4 | $460K | Hold |
86
| – | – | ﹤0.01% | 3387 |
|
|
2017
Q3 | $764K | Hold |
86
| – | – | ﹤0.01% | 3215 |
|
|
2017
Q2 | $642K | Sell |
86
-15
| -15% | -$104K | ﹤0.01% | 3270 |
|
|
2017
Q1 | $644K | Buy |
101
+43
| +74% | +$216K | ﹤0.01% | 3214 |
|
|
2016
Q4 | $666K | Buy |
58
+1
| +2% | +$14K | ﹤0.01% | 3171 |
|
|
2016
Q3 | $796K | Buy |
57
+13
| +30% | +$186K | ﹤0.01% | 3067 |
|
|
2016
Q2 | $671K | Buy |
44
+2
| +5% | +$27.4K | ﹤0.01% | 3088 |
|
|
2016
Q1 | $525 | Buy |
42
+13
| +45% | +$168K | ﹤0.01% | 3211 |
|
|
2015
Q4 | $573K | Hold |
29
| – | – | ﹤0.01% | 3207 |
|
|
2015
Q3 | $387K | Buy |
29
+3
| +12% | +$53.3K | ﹤0.01% | 3342 |
|
|
2015
Q2 | $453K | Buy |
26
+6
| +30% | +$128K | ﹤0.01% | 3250 |
|
|
2015
Q1 | $378K | Buy |
20
+6
| +43% | +$105K | ﹤0.01% | 3312 |
|
|
2014
Q4 | $173K | Hold |
14
| – | – | ﹤0.01% | 3632 |
|
|
2014
Q3 | $205K | Buy |
+14
| New | +$216K | ﹤0.01% | 3562 |
|